Indivior Pharmaceuticals Inc (INDV) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Indivior Pharmaceuticals Inc (INDV) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $4.78B, listed on NASDAQ, employing roughly 1,030 people, carrying a beta of 1.20 to the broader market. Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Led by Joseph J. Ciaffoni, public since 2014-12-29.
Snapshot as of May 15, 2026.
- Spot Price
- $36.67
- ATM IV
- 49.9%
- IV Skew 25Δ
- 0.140
- IV Rank
- 4.6%
- IV Percentile
- 30.2%
- Term Structure Slope
- 0.008
As of May 15, 2026, Indivior Pharmaceuticals Inc (INDV) at-the-money implied volatility is 49.9%. IV rank is 4.6% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 30.2%. The 25-delta skew is +0.140: calls carry premium over puts, indicating upside speculation or squeeze risk. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
INDV Strategy Selection at Current Volatility Levels
For Indivior Pharmaceuticals Inc options at 49.9% ATM IV, low IV rank (4.6%) favors premium-buying or long-vol structures: long calls or puts, debit spreads, calendar spreads, long straddles. The risk: low-rank regimes can persist for months while time decay eats premium-buyers alive. The 25-delta skew tilts to calls, so call-credit spreads or covered-call writes harvest more premium than put-credit spreads of the same width. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
INDV highest implied-volatility contracts
| Type | Strike | Expiration | Volume | OI | IV | Bid | Ask |
|---|---|---|---|---|---|---|---|
| CALL | $40.00 | Aug 21, 2026 | 3 | 16.6K | 51.2% | $2.50 | $3.70 |
| CALL | $40.00 | Aug 21, 2026 | 3 | 16.6K | 51.2% | $2.50 | $3.70 |
Top 2 contracts from the ORATS-sourced nightly scan; ranked by iv within the broader S&P 500/400/600 + ETF universe.
Frequently asked INDV volatility skew questions
- What is the current INDV ATM implied volatility?
- As of May 15, 2026, Indivior Pharmaceuticals Inc (INDV) at-the-money implied volatility is 49.9%. IV rank is 4.6% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is INDV IV high or low historically?
- IV is subdued relative to its 1-year history, conditions that typically favor premium-buying strategies (long calls, long puts, debit spreads, calendar spreads).
- What does INDV volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Indivior Pharmaceuticals Inc shows upside-skewed pricing: 25-delta calls trade richer than 25-delta puts, often reflecting upside speculation or squeeze risk. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.